Objectives

The main aim of the study was: • To determine whether prophylactic administration of granulocyte macrophage colony stimulating factor (GMCSF) in patients undergoing intensive chemotherapy for solid tumor malignancies reduced the duration of neutropenia.

Table 17.45 Characteristics of patients.a,b

Number of Number of

Chemotherapy GMCSF

Table 17.45 Characteristics of patients.a,b

Number of Number of

Chemotherapy GMCSF

Age

Gender

Diagnosis

Courses

Courses

Was this article helpful?

0 0

Post a comment